Sotera Health Financial Statements
NASDAQ: SHCHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Sotera Health revenue and earnings
In fiscal 2025, Sotera Health generated $1.16 billion in revenue, up 5.7% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $77.9 million (+75.6% year over year), for a net margin of 6.7% versus a median of 4.0% in the prior 5 years. Gross margin was 55.5% (up from 54.7%).
Diluted earnings per share came in at $0.27, up from $0.16. Over the last 5 fiscal years, SHC's revenue has grown at a 7.3% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Sotera Health income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.16B | 1.10B | 1.05B | 1.00B | 931.48M | 818.16M | 778.33M |
| Revenue growth (YoY) | +5.74% | +4.88% | +4.54% | +7.75% | +13.85% | +5.12% | — |
| Cost of Revenue | 518.08M | 498.15M | 472.13M | 446.68M | 412.81M | 374.59M | 382.90M |
| Gross Profit | 645.53M | 602.29M | 577.16M | 557.00M | 518.67M | 443.57M | 395.43M |
| Operating Expenses | — | 304.67M | 300.47M | 308.65M | 261.94M | 237.55M | 211.83M |
| Selling, General & Admin | 252.76M | 242.63M | 236.67M | 245.71M | 198.16M | 178.53M | 147.48M |
| Operating Income | — | 297.63M | 276.69M | 248.35M | 256.73M | 206.02M | 183.60M |
| Other Income (Expense) | 8.55M | 5.31M | 7.37M | 6.44M | 15.20M | 9.41M | 7.25M |
| Pretax Income | 147.51M | 113.87M | 106.03M | -243.11M | 175.72M | -38.86M | -916.00K |
| Income Tax | 69.56M | 69.48M | 54.65M | -9.54M | 58.59M | -1.37M | 19.51M |
| Net Income | 77.95M | 44.40M | 51.38M | -233.57M | 116.88M | -38.62M | -20.85M |
| Net Income growth (YoY) | +75.57% | -13.58% | — | -299.83% | — | — | — |
| EPS (Basic) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 | -0.16 | -0.09 |
| EPS (Diluted) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 | -0.16 | -0.09 |
| Shares Outstanding (Basic) | 283.96M | 282.78M | 281.01M | 280.10M | 279.23M | 237.70M | 232.40M |
| Shares Outstanding (Diluted) | 286.42M | 284.91M | 283.22M | 280.10M | 279.38M | 237.70M | 232.40M |
| EBITDA | — | 381.93M | 353.29M | 312.65M | 320.93M | 269.32M | 250.30M |
| Gross Margin | 55.48% | 54.73% | 55.00% | 55.50% | 55.68% | 54.22% | 50.81% |
| Operating Margin | — | 27.05% | 26.37% | 24.74% | 27.56% | 25.18% | 23.59% |
| Net Margin | 6.70% | 4.03% | 4.90% | -23.27% | 12.55% | -4.72% | -2.68% |
This table shows 7 annual periods of Sotera Health's income statement, from FY 2025 back to FY 2019, across 18 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow SHC's reporting calendar. What is a income statement?